Moscow, Russia--(Marketwired – 18 Novebmer 2014) - Cromos™ Pharma, an international full-service CRO announced today that it launched Corium Research, a state of the art dermatology site research organization (SRO) comprised of 24 specialized dermatology medical centers and clinics in Moscow, Russia.
"Corium Research is an organic addition to the scope of services that are being provided by Cromos™ Pharma," said Dr. Vlad Bogin, MD, FACP, company's CEO. "We've collaborated with each institution in the past, have built strong working relationships with its investigators and can attest to their patient oriented approach, clinical professionalism, the scientific rigor and quality of their trial data. All 24 research institutions operate as a single legal entity, thus optimizing trial-related logistics, accelerating study start-up times and patient enrollment rates, simplifying administrative processes and reducing overall study costs. "
"Corium Research patient base of over 11 million makes it one of the largest dermatology site research organizations in the world," added Dr. Andrey Tarakanov, MD, Cromos™ Pharma's Managing Director. "Company's unique positioning, focus, and vast study naïve patient base translates into an unprecedented opportunity to rapidly accelerate clinical research in dermatology. "Cromos™ Pharma, the parent organization, will provide administrative, logistical and project management support, quality assurance training and oversight services for Corium Research.
About Cromos™ Pharma, LLC
Cromos™ Pharma, LLC is a contract research organization (CRO) with operations in the post-Soviet space and in Eastern/Central Europe. The company provides a full spectrum of trial-related services which include regulatory approvals, medical writing, feasibility assessments, monitoring, project management and warehousing. Cromos™ Pharma, LLC is a privately owned company
Ukraine, the eight largest European country by population, is an attractive location for sponsors conducting clinical research for a number of key reasons. Cromos Pharma has been successfully managing clinical trials in Ukraine since 2006. This article looks at just some of the benefits of locating your next study here.
Cromos Pharma is continuously developing and looking to explore new territories when it comes to clinical research. In line with this spirit of discovery, we will be shortly commencing a new project in Uzbekistan supporting a study being conducted by the Swiss Tropical and Public Health Institute.
Cromos Pharma is delighted to be taking part in the upcoming DIA Europe conference (15 – 19 March 2021) and BIO-Europe Spring (22-25 March 2021).
February 11th is International Women and Girls in Science Day. A joint UNESCO and UN-Women initiative, it aims to promote the role of #WomenInScience and to challenge some of the barriers to girls pursuing a career in science.
Are you a sponsor seeking to conduct clinical trials in the European Union but do not have a registered office in the European Economic Area? If so, in order to comply with the European Union Clinical Trial Directive, you are required to work with a Legal Representative registered in an EEA country.
Each 4th February, #WorldCancerDay aims to raise awareness of the global personal, social and economic burden of cancer. World Cancer Day was established in Paris at the first World Cancer Summit in 2000.
As 2021 begins, many countries are grappling with a renewed surge of COVID-19 infections necessitating further public health restrictions putting more pressure on health systems, societies and global economies. The task of rolling out approved vaccines is increasingly urgent. Almost 16 million doses of COVID-19 vaccines have been administered to date in 37 countries worldwide according to data compiled by Bloomberg ( updated 7 Jan 2021).
Tuesday 1 December marked World AIDS Day 2020. Although throughout this year our focus has been on the coronavirus pandemic, World AIDS Day is an opportunity to reflect on another pandemic where a virus passed from animals to humans with devastating consequences. To date 77 million people worldwide have been infected with HIV. In spite of innovative new treatments 35 million people have died from the virus.
If you missed the live webinar “Where in the world should I locate my pivotal clinical trial?” you can now watch the recording by clicking here. The webinar hosted by the Society of Physician Entrepreneurs (SoPE) and Workforce Genetics features Cromos Pharma's CEO Vlad Bogin, M.D, FACP.